News

Newsletter

INPI publishes communication on new sequence listing standard for patent applications in Brazil

On 7 June 2022, in the Official Gazette 2683, the Brazilian patent office published a communication regarding the new standard for submission of sequence listings for patent applications in Brazil.

The sequence listings of applications filed as from 07/01/2022 must be submitted in the new WIPO ST.26 standard (single file in XML format).

As for applications filed on or before 06/30/2022, the WIPO ST.25 standard must be maintained, even upon re-submission of the sequence listing.

The BRPTO informs that a tool developed by WIPO for creating, editing and verifying sequence listings in the WIPO ST.26 standard will be available on the institute’s website.

Finally, as of 07/01/2022, sequence listings in both formats (depending on the case) will be available on the INPI website.

Back

Last related news

9 de December de 2025

Fake Software Resellers: A Growing Risk for Users and a New Front in IP Enforcement

For years, the most common form of software piracy involved downloading cracked or unauthorized versions from websites offering them for free. Although Fake Software Resellers: A Growing Risk for Users and a New Front in IP Enforcement

  • Kasznar Leonardos
  • Ler notícia

    25 de November de 2025

    Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case

    Kasznar Leonardos is pleased to announce an important victory before the São Paulo Court of Appeals in a software license compliance action Significant Win for Kasznar Leonardos as Appellate Court Raises Compensation in Software Infringement Case

  • Kasznar Leonardos
  • Ler notícia

    13 de November de 2025

    ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

    The National Health Surveillance Agency (Anvisa) published on Monday, November 10, 2025, the Collegiate Board Resolution (RDC) No. 997/2025, which institutes exceptional ANVISA Publishes Exceptional Rule to Expedite Analysis of Medicines and Biological Products

  • Kasznar Leonardos
  • Ler notícia